Reaction
Meningitis Bacterial reporting signals
As of the last recalculation, Meningitis Bacterial appears in 1,414 FAERS reports alongside 38 co-occurring drug terms. The strongest observed disproportionality signal is CEFEPIME HYDROCHLORIDE (PRR 21.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Cefepime Hydrochloride | 23 | 21.3 | 21.4 |
| Cefepime | 20 | 20.8 | 20.8 |
| Ampicillin | 11 | 19.7 | 19.7 |
| Ampicillin Sodium | 11 | 19.7 | 19.7 |
| Ceftriaxone | 42 | 19.4 | 19.4 |
| Meropenem | 41 | 19.3 | 19.4 |
| Methylprednisolone Acetate | 10 | 18.5 | 18.5 |
| Ceftriaxone Sodium | 45 | 17.8 | 17.8 |
| Amphotericin B | 14 | 16.6 | 16.6 |
| Rifampicin | 11 | 16.1 | 16.1 |
| Iohexol | 8 | 14.3 | 14.3 |
| Blinatumomab | 10 | 14.2 | 14.2 |
| Vancomycin | 53 | 14.0 | 14.0 |
| Micafungin Sodium | 8 | 14.0 | 14.0 |
| Vancomycin Hydrochloride | 60 | 13.9 | 14.0 |
| Cytarabine | 50 | 12.7 | 12.7 |
| Basiliximab | 10 | 12.6 | 12.6 |
| Melphalan | 19 | 12.4 | 12.5 |
| Valganciclovir Hydrochloride Powder, | 10 | 12.1 | 12.2 |
| Melphalan Hydrochloride | 19 | 11.3 | 11.3 |
| Pyrazinamide | 7 | 11.0 | 11.0 |
| Pegaspargase | 9 | 10.9 | 10.9 |
| Mycophenilic Acid | 15 | 10.8 | 10.8 |
| Fludarabine Phosphate | 28 | 10.7 | 10.7 |
| Ravulizumab | 9 | 9.9 | 9.9 |
| Ifosfamide | 14 | 9.7 | 9.7 |
| Bupivacaine | 6 | 9.5 | 9.5 |
| Tacrolimus Ointment 0.1% | 75 | 9.3 | 9.3 |
| Tacrolimus Extended-Release Capsules | 75 | 9.3 | 9.3 |
| Phenobarbital | 9 | 9.2 | 9.2 |
| Temozolomide | 13 | 9.2 | 9.2 |
| Thiotepa | 5 | 7.7 | 7.7 |
| Etoposide | 37 | 7.6 | 7.6 |
| Linezolid | 14 | 7.0 | 7.0 |
| Carfilzomib | 11 | 5.8 | 5.8 |
| Palivizumab | 5 | 4.8 | 4.8 |
| Remdesivir | 4 | 4.4 | 4.4 |
| Pomalidomide | 17 | 2.5 | 2.5 |